Association of Cytomegalovirus Infection and Disease With Death and Graft Loss After Liver Transplant in High-Risk Recipients (Q84728766)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21827609%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

title

Association of cytomegalovirus infection and disease with death and graft loss after liver transplant in high-risk recipients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21827609%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Association of Cytomegalovirus Infection and Disease With Death and Graft Loss After Liver Transplant in High-Risk Recipients (English)

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2011.03618.X

9 December 2024

main subject

cytomegaloviral disease

1 reference

W. Bosch

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21827609

9 December 2024

M. G. Heckman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21827609

9 December 2024

N. N. Diehl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21827609

9 December 2024

J. A. Shalev

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21827609

9 December 2024

S. Pungpapong

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21827609

9 December 2024

W. C. Hellinger

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21827609

9 December 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21827609

9 December 2024

publication date

9 August 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21827609%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

9 February 2020

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1600-6143.2011.03618.x

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21827609

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1600-6143.2011.03618.x

9 December 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2011.03618.X

https://api.elsevier.com/content/article/PII:S1600613522281210?httpAccept=text/xml

9 December 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2011.03618.X

https://api.elsevier.com/content/article/PII:S1600613522281210?httpAccept=text/plain

9 December 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2011.03618.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-6143.2011.03618.x/fullpdf

9 December 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2011.03618.X

American Journal of Transplantation

9 December 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21827609%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21827609%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21827609%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

2181-2189

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21827609%20AND%20SRC:MED&resulttype=core&format=json

Cytomegalovirus infection after liver transplantation: current concepts and challenges

9 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2011.03618.X

CMV infection, diagnosis and antiviral strategies after liver transplantation

9 December 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2011.03618.X

Cytomegalovirus hepatitis in liver transplantation: prospective analysis of 93 consecutive orthotopic liver transplantations

9 December 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2011.03618.X

Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group [corrected].

9 December 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2011.03618.X

Preemptive use of oral ganciclovir to prevent cytomegalovirus infection in liver transplant patients: a randomized, placebo-controlled trial.

9 December 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2011.03618.X

Delayed-onset primary cytomegalovirus disease after liver transplantation

9 December 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2011.03618.X

Late-onset cytomegalovirus disease in liver transplant recipients despite antiviral prophylaxis

9 December 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2011.03618.X

Impact of cytomegalovirus in organ transplant recipients in the era of antiviral prophylaxis

9 December 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2011.03618.X

9 December 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2011.03618.X

Definitions of cytomegalovirus infection and disease in transplant recipients

9 December 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2011.03618.X

Relaxing the rule of ten events per variable in logistic and Cox regression

9 December 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2011.03618.X

Effect of cytomegalovirus infection status on first-year mortality rates among orthotopic liver transplant recipients. The Boston Center for Liver Transplantation CMVIG Study Group

9 December 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2011.03618.X

Significance of cytomegalovirus for long-term survival after orthotopic liver transplantation: a prospective derivation and validation cohort analysis.

9 December 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2011.03618.X

Changing impact of cytomegalovirus in liver transplantation -- a single centre experience of more than 1000 transplantations without ganciclovir prophylaxis

9 December 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2011.03618.X

Cytomegalovirus Disease as a Risk Factor for Graft Loss and Death After Orthotopic Liver Transplantation

9 December 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2011.03618.X

Meta-analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients

9 December 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2011.03618.X

Effect of antiviral chemoprophylaxis on adverse clinical outcomes associated with cytomegalovirus after liver transplantation

9 December 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2011.03618.X

Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients

9 December 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2011.03618.X

Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir

9 December 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2011.03618.X

The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients

9 December 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2011.03618.X

Extended valganciclovir prophylaxis in D+/R- kidney transplant recipients is associated with long-term reduction in cytomegalovirus disease: two-year results of the IMPACT study

9 December 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2011.03618.X

Cytomegalovirus in solid organ transplant recipients

9 December 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2011.03618.X

International consensus guidelines on the management of cytomegalovirus in solid organ transplantation

9 December 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2011.03618.X

Prolonged prophylaxis with valganciclovir is cost effective in reducing posttransplant cytomegalovirus disease within the United States

9 December 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-6143.2011.03618.X

9 December 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21827609%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21827609%20AND%20SRC:MED&resulttype=core&format=json